Viewing Study NCT05068102


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-01-15 @ 3:42 AM
Study NCT ID: NCT05068102
Status: RECRUITING
Last Update Posted: 2025-10-15
First Post: 2021-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Squamous Cell of Head and Neck (HNSCC) View
None Melanoma View
None Non-small Cell Lung Cancer (NSCLC) View
Keywords: